Amyris Inc. (NASDAQ: AMRS) has announced that it has reached exclusive terms to purchase MenoLabs LLC assets to drive research for women’s health and also enhance...
Amyris Inc. (NASDAQ: AMRS) and ImmunityBio (NASDAQ: IBRX) have announced the closing of a previously announced JV agreement to expedite the commercialization of a flagship next-gen...
Delta 9 Cannabis Inc. (OTCMKTS: DLTNF) has announced the appointment of David Kideckel to the newly created EVP Head of Strategy, Corporate Development & Capital Markets...
Amyris Inc (NASDAQ: AMRS), a synthetic biotechnology company with activity in Beauty, Clean Health, and Wellness markets, recently announced its financial results for the second quarter...
Amyris Inc (NASDAQ: AMRS) is a top synthetic biotech corporation that operates in the wellness, beauty, and clean health industry via a leading supplier of natural and...
Amyris Inc (NASDAQ:AMRS) posted record production of CBG (Cannabigerol) in Q1 2021 for skincare treatments. Amyris used the fermentation process to achieve record production of CBG...
Amyris Inc (NASDAQ:AMRS) posted record revenues of $80 million (up 71% QoQ) in Q4 2020. It is almost double to revenues in Q3 2020. Also, its...
Amyris Inc (NASDAQ:AMRS) has completed the first shipment of cannabinoids to its associate – LAVVAN. The company is also gearing to meet the second shipment of...
